SubIntro

SubIntro is a medical technology company specializing in the development of a proprietary platform for the subcutaneous delivery of large-volume and high-viscosity biologics. The company's technology aims to shift the administration of complex therapeutics from time-consuming intravenous infusions in clinical settings to rapid, self-administered subcutaneous injections. By enabling the delivery of volumes significantly larger than standard autoinjectors, SubIntro seeks to improve patient convenience, treatment adherence, and overall healthcare efficiency. The firm is led by a team of experts with extensive backgrounds in drug delivery and biotechnology. SubIntro is headquartered in San Diego, California, and focuses on therapeutic areas such as oncology and immunology.